|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/48 | |
| A61K 9/08 | |||
| A61K 9/19 | |||
| A61K 47/02 | |||
| A61K 47/10 | |||
| A61K 47/18 |
| (11) | Number of the document | 3167897 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15203085.4 |
| Date of filing the European patent application | 2010-09-21 | |
| (97) | Date of publication of the European application | 2017-05-17 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 244353 P | 2009-09-21 | US |
| (72) |
MATTHIESSEN, H., Peter, AT
TURECEK, Peter, L., AT
SCHWARZ, Hans-Peter, AT
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS |
| STABILIZED LIQUID AND LYOPHILIZED ADAMTS13 FORMULATIONS |